Abstract
1. The concentration of N1-dimethylacroyl sulphanilamide (irgamid) in the blood and cerebro-spinal fluid and the excretion in the urine have been studied after various methods of administration.
2. High blood concentrations can be easily reached and maintained, and with smaller doses than are required with sulphapyridine or sulphanilamide.
3. The toxic effects in the cases studied were practically negligible—this may be correlated with the relatively small degree of acetylation. The drug is readily absorbed and well tolerated by the intramuscular route.
4. There is reason to believe, however, that the therapeutic efficiency is not high.
Footnotes
- Received August 29, 1944.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.